ISRG — Intuitive Surgical Inc. stock price and chart

ISRG

Intuitive Surgical Inc.Stock · HealthcareNasdaq-100 0.6% · Nasdaq Composite 0.3% · S&P 500 0.2% · Russell 1000 0.2% · US Stock Market 0.2% · Russell 3000 0.2% · S&P 500 Equal Weight 0.2% · MSCI World 0.2% · MSCI ACWI 0.2%

$369.15+2.41%

as of market close, Sep 11, 2026

☾ AH — —

PeersMRNALLYUNHJNJMRKABBV

Technical analysis2

Overlay lines0

Addendum charts0

VolumeSS

20162019202120242026

100.0150.0200.0250.0300.0350.0400.0450.0500.0550.0020.0M$369.15

2026-09-11

Price$369.15

MA20$411.83

MA50$468.42

Vol16.2M

What would $1,000 invested in ISRG be worth today? →

ISRG returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $369.15
Change YTD: -34.82%
Next earnings: Oct 20, 2026
Market cap: 130.4B2016-09 28.1B2026-09 130.6B+365.0% over the window
Enterprise value: 125.5B
Shares outstanding: 353.3M2016-06 346.4M2026-06 353.3M+2.0% over the window
52W low: $328.57
52W high: $603.88
From 52W high: -38.87%
From 52W low: +12.35%
52W range: 15%
Beta: 1.46

Volume

Rel volume: 1.32×
30D volume: 2.5M
30D $ vol: 957.5M

Fundamentals

Sales (ttm): 11B2016-06 2.5B2026-06 11B+336.0% over the window
Sales/share: $31.232016-06 $7.312026-06 $31.23+327.6% over the window
EPS (ttm): $8.722016-06 $1.962026-06 $8.72+345.1% over the window
FCF (ttm): 3.2B2016-06 916.7M2026-06 3.2B+251.5% over the window
FCF/share: $9.122016-06 $2.652026-06 $9.12+244.7% over the window
Book value/share: $51.432016-06 $14.962026-06 $51.43+243.9% over the window
Net margin: 28.45%2016-06 26.8%2026-06 28.4%+6.1% over the window
ROE: 17.28%2016-06 13.1%2026-06 17.3%+32.0% over the window
ROA: 15.04%2016-06 11.7%2026-06 15.0%+28.2% over the window
Current ratio: 4.962016-06 5.782026-06 4.96-14.1% over the window

Growth (CAGR, ttm) · 10Y

Sales: +20.68%2025-06-30 → 2026-06-309.1B → 11B (+20.7% total)+18.30%2023-06-30 → 2026-06-306.7B → 11B (+65.6% total)+16.41%2021-06-30 → 2026-06-305.2B → 11B (+113.7% total)+15.87%2016-06-30 → 2026-06-302.5B → 11B (+336.0% total)
Net income: +20.39%2025-06-30 → 2026-06-302.6B → 3.1B (+20.4% total)+30.10%2023-06-30 → 2026-06-301.4B → 3.1B (+120.3% total)+14.11%2021-06-30 → 2026-06-301.6B → 3.1B (+93.4% total)+16.56%2016-06-30 → 2026-06-30678.2M → 3.1B (+362.8% total)
FCF: +61.64%2025-06-30 → 2026-06-302B → 3.2B (+61.6% total)+39.87%2023-06-30 → 2026-06-301.2B → 3.2B (+173.7% total)+14.17%2021-06-30 → 2026-06-301.7B → 3.2B (+93.9% total)+13.40%2016-06-30 → 2026-06-30916.7M → 3.2B (+251.5% total)
Shares: -1.45%2025-06-30 → 2026-06-30358.5M → 353.3M (-1.5% total)+0.18%2023-06-30 → 2026-06-30351.4M → 353.3M (+0.5% total)-0.17%2021-06-30 → 2026-06-30356.2M → 353.3M (-0.8% total)+0.20%2016-06-30 → 2026-06-30346.4M → 353.3M (+2.0% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +21.73%2025-06-30 → 2026-06-30$7.17 → $8.72 (+21.7% total)+29.85%2023-06-30 → 2026-06-30$3.98 → $8.72 (+119.0% total)+1.22%2021-06-30 → 2026-06-30$8.21 → $8.72 (+6.3% total)+16.11%2016-06-30 → 2026-06-30$1.96 → $8.72 (+345.1% total)
Sales/share: +22.45%2025-06-30 → 2026-06-30$25.51 → $31.23 (+22.4% total)+18.08%2023-06-30 → 2026-06-30$18.97 → $31.23 (+64.7% total)+16.60%2021-06-30 → 2026-06-30$14.49 → $31.23 (+115.5% total)+15.64%2016-06-30 → 2026-06-30$7.31 → $31.23 (+327.6% total)
FCF/share: +64.02%2025-06-30 → 2026-06-30$5.56 → $9.12 (+64.0% total)+39.61%2023-06-30 → 2026-06-30$3.35 → $9.12 (+172.2% total)+14.36%2021-06-30 → 2026-06-30$4.66 → $9.12 (+95.5% total)+13.18%2016-06-30 → 2026-06-30$2.65 → $9.12 (+244.7% total)
Book value/share: +3.31%2025-06-30 → 2026-06-30$49.78 → $51.43 (+3.3% total)+15.00%2023-06-30 → 2026-06-30$33.81 → $51.43 (+52.1% total)+11.07%2021-06-30 → 2026-06-30$30.42 → $51.43 (+69.1% total)+13.15%2016-06-30 → 2026-06-30$14.96 → $51.43 (+243.9% total)
Price: -19.03%2025-09-11 → 2026-09-11$455.85 → $369.15 (-19.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+6.88%2023-09-11 → 2026-09-11$302.35 → $369.15 (+22.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+1.59%2021-09-10 → 2026-09-11$341.16 → $369.15 (+8.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+17.25%2016-09-09 → 2026-09-11$75.14 → $369.15 (+391.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: -19.03%2025-09-11 → 2026-09-11$455.85 → $369.15 (-19.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+6.88%2023-09-11 → 2026-09-11$302.35 → $369.15 (+22.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+1.59%2021-09-10 → 2026-09-11$341.16 → $369.15 (+8.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+17.25%2016-09-09 → 2026-09-11$75.14 → $369.15 (+391.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 42.3×2016-09 38.902026-09 41.61+7.0% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 37.8×2016-09 30.312026-09 37.84+24.9% over the window
Fwd P/E: 28.9×
P/S (ttm)Market cap ÷ TTM revenue.: 11.8×2016-09 10.702026-09 11.84+10.6% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 7.2×2016-09 5.072026-09 7.19+41.8% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 40.5×2016-09 27.562026-09 40.53+47.1% over the window
EV/EBITDA (fy): 35.3×
EV/Sales (ttm): 11.4×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 2.47%2016-06 3.3%2026-06 2.3%-30.3% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 353.3M ÷ 358.5M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 1.45%
Shareholder yield (realized, 1y)Realized buyback yield + dividends paid over the same year ÷ the market cap at the start of that year — cash received per dollar an owner actually held. Both figures come from the company's own SEC filings.: 1.45%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($3.6B) ÷ today's market cap ($130.4B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 2.73%2016-06 0.5%2026-06 2.5%+451.9% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $3.6B + TTM dividends $0) ÷ today's market cap ($130.4B). Same caveat as the cash buyback yield.: 2.73%2016-06 0.5%2026-06 2.5%+451.9% over the window

Vs own 10Y history

P/E: 8th
P/OI: 11th
P/S: 9th
P/B: 13th
P/FCF: 11th

Bar = where today’s multiple sits in ISRG’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · windows as of 2026-09-11

+2.41%

-0.18%

-8.00%

-10.60%

YTD

-34.82%

-17.96%

+3.35%

Financial statements

Open full ISRG financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	-8.44%	-0.65%
JNJ	Johnson & Johnson	+2.31%	-0.29%
ABBV	AbbVie Inc.	+3.36%	+0.83%
MRK	Merck & Co. Inc.	+8.28%	-0.54%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-6.53%	-2.37%
TMO	Thermo Fisher Scientific Inc.	+1.13%	+1.10%
AMGN	Amgen Inc.	-8.80%	-1.34%
GILD	Gilead Sciences Inc.	+5.78%	-0.75%

Intuitive Surgical Inc. (ISRG) trades at $369.15 with a live price and an interactive chart covering 26+ years of daily price history, plus key valuation metrics. ChartRow also publishes ISRG’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full ISRG financial statements →

ISRG — Intuitive Surgical Inc. price, chart and key statistics